Dopamine in drug abuse and addiction: results from imaging studies and treatment implications View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2004-04-06

AUTHORS

N D Volkow, J S Fowler, G-J Wang, J M Swanson

ABSTRACT

The involvement of dopamine in drug reinforcement is well recognized but its role in drug addiction is much less clear. Imaging studies have shown that the reinforcing effects of drugs of abuse in humans are contingent upon large and fast increases in dopamine that mimic but exceed in the intensity and duration those induced by dopamine cell firing to environmental events. In addition, imaging studies have also documented a role of dopamine in motivation, which appears to be encoded both by fast as well as smooth DA increases. Since dopamine cells fire in response to salient stimuli, the supraphysiological activation by drugs is likely to be experienced as highly salient (driving attention, arousal conditioned learning and motivation) and may also reset the thresholds required for environmental events to activate dopamine cells. Indeed, imaging studies have shown that in drug-addicted subjects, dopamine function is markedly disrupted (decreases in dopamine release and in dopamine D2 receptors in striatum) and this is associated with reduced activity of the orbitofrontal cortex (neuroanatomical region involved with salience attribution and motivation and implicated in compulsive behaviors) and the cingulate gyrus (neuroanatomical region involved with inhibitory control and attention and implicated in impulsivity). However, when addicted subjects are exposed to drug-related stimuli, these hypoactive regions become hyperactive in proportion to the expressed desire for the drug. We postulate that decreased dopamine function in addicted subjects results in decreased sensitivity to nondrug-related stimuli (including natural reinforcers) and disrupts frontal inhibition, both of which contribute to compulsive drug intake and impaired inhibitory control. These findings suggest new strategies for pharmacological and behavioral treatments, which focus on enhancing DA function and restoring brain circuits disrupted by chronic drug use to help motivate the addicted subject in activities that provide alternative sources of reinforcement, counteract conditioned responses, enhance their ability to control their drive to take drugs and interfere with their compulsive administration. More... »

PAGES

557-569

References to SciGraph publications

  • 2000-12. Involvement of the Nucleus Accumbens and Medial Prefrontal Cortex in the Expression of Conditioned Hyperactivity to a Cocaine-Associated Environment in Rats in NEUROPSYCHOPHARMACOLOGY
  • 1998-11. Naltrexone administration affects ad libitum smoking behavior in PSYCHOPHARMACOLOGY
  • 1997-09. Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat in PSYCHOPHARMACOLOGY
  • 1996-06. Interaction of expectancy and the pharmacological effects ofd-amphetamine: subjective effects and self-administration in PSYCHOPHARMACOLOGY
  • 2002-10-14. The GABAB Receptor Agonist Baclofen Attenuates Cocaine- and Heroin-Seeking Behavior by Rats in NEUROPSYCHOPHARMACOLOGY
  • 2002-01-22. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration in NATURE NEUROSCIENCE
  • 1999-04. Relative reward preference in primate orbitofrontal cortex in NATURE
  • 1995-10. Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence in PSYCHOPHARMACOLOGY
  • 1997-03. Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data in PSYCHOPHARMACOLOGY
  • 1997-08. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors in NATURE
  • 1999-01. Distribution of Dopamine D3 Receptor Expressing Neurons in the Human Forebrain: Comparison with D2 Receptor Expressing Neurons in NEUROPSYCHOPHARMACOLOGY
  • 1997-04. Relationship between subjective effects of cocaine and dopamine transporter occupancy in NATURE
  • 1994-08. Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine in PSYCHOPHARMACOLOGY
  • 1998-09-01. Anti-hyperactivity medication: methylphenidate and amphetamine in MOLECULAR PSYCHIATRY
  • 2001-10. A cannabinoid mechanism in relapse to cocaine seeking in NATURE MEDICINE
  • 2000-09. Context-specific Enhancement of Glutamate Transmission by Cocaine in NEUROPSYCHOPHARMACOLOGY
  • 1997-04. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects in NATURE
  • 2002-09-01. Pharmacotherapy of addictions in NATURE REVIEWS DRUG DISCOVERY
  • 1999-03-01. Dopamine transporters increase in human brain after alcohol withdrawal in MOLECULAR PSYCHIATRY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/sj.mp.4001507

    DOI

    http://dx.doi.org/10.1038/sj.mp.4001507

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1003639866

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/15098002


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Neurosciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Attention Deficit Disorder with Hyperactivity", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Brain", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Child", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dopamine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neurons", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Substance-Related Disorders", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Psychiatry, State University of New York at Stony Brook, Stony Brook, NY, USA", 
              "id": "http://www.grid.ac/institutes/grid.36425.36", 
              "name": [
                "National Institute on Drug Abuse, Bethesda, MD, USA", 
                "National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA", 
                "Medical Department, Brookhaven National Laboratory, Upton, NY, USA", 
                "Department of Psychiatry, State University of New York at Stony Brook, Stony Brook, NY, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Volkow", 
            "givenName": "N D", 
            "id": "sg:person.01144035310.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144035310.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Chemistry Department, Brookhaven National Laboratory, Upton, NY, USA", 
              "id": "http://www.grid.ac/institutes/grid.202665.5", 
              "name": [
                "Chemistry Department, Brookhaven National Laboratory, Upton, NY, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fowler", 
            "givenName": "J S", 
            "id": "sg:person.0735132433.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735132433.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical Department, Brookhaven National Laboratory, Upton, NY, USA", 
              "id": "http://www.grid.ac/institutes/grid.202665.5", 
              "name": [
                "Medical Department, Brookhaven National Laboratory, Upton, NY, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wang", 
            "givenName": "G-J", 
            "id": "sg:person.015403046757.84", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015403046757.84"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pediatrics, University of California, Irvine, CA, USA", 
              "id": "http://www.grid.ac/institutes/grid.266093.8", 
              "name": [
                "Department of Pediatrics, University of California, Irvine, CA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Swanson", 
            "givenName": "J M", 
            "id": "sg:person.013047163317.72", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013047163317.72"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nrd897", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026706324", 
              "https://doi.org/10.1038/nrd897"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/19525", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006488209", 
              "https://doi.org/10.1038/19525"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/386830a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008799479", 
              "https://doi.org/10.1038/386830a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002130050207", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006734694", 
              "https://doi.org/10.1007/s002130050207"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.mp.4000421", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013128731", 
              "https://doi.org/10.1038/sj.mp.4000421"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/41567", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019786931", 
              "https://doi.org/10.1038/41567"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02246020", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016990125", 
              "https://doi.org/10.1007/bf02246020"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm1001-1151", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046230934", 
              "https://doi.org/10.1038/nm1001-1151"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1016/s0893-133x(00)00100-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018257913", 
              "https://doi.org/10.1016/s0893-133x(00)00100-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002130050365", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040792669", 
              "https://doi.org/10.1007/s002130050365"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1016/s0893-133x(98)00066-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053553631", 
              "https://doi.org/10.1016/s0893-133x(98)00066-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nn798", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046908280", 
              "https://doi.org/10.1038/nn798"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02246489", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038618321", 
              "https://doi.org/10.1007/bf02246489"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002130050756", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003741794", 
              "https://doi.org/10.1007/s002130050756"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02245566", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025660547", 
              "https://doi.org/10.1007/bf02245566"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1016/s0893-133x(00)00162-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046522838", 
              "https://doi.org/10.1016/s0893-133x(00)00162-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/386827a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052945590", 
              "https://doi.org/10.1038/386827a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.npp.1300088", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052285316", 
              "https://doi.org/10.1038/sj.npp.1300088"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.mp.4000514", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031823330", 
              "https://doi.org/10.1038/sj.mp.4000514"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2004-04-06", 
        "datePublishedReg": "2004-04-06", 
        "description": "The involvement of dopamine in drug reinforcement is well recognized but its role in drug addiction is much less clear. Imaging studies have shown that the reinforcing effects of drugs of abuse in humans are contingent upon large and fast increases in dopamine that mimic but exceed in the intensity and duration those induced by dopamine cell firing to environmental events. In addition, imaging studies have also documented a role of dopamine in motivation, which appears to be encoded both by fast as well as smooth DA increases. Since dopamine cells fire in response to salient stimuli, the supraphysiological activation by drugs is likely to be experienced as highly salient (driving attention, arousal conditioned learning and motivation) and may also reset the thresholds required for environmental events to activate dopamine cells. Indeed, imaging studies have shown that in drug-addicted subjects, dopamine function is markedly disrupted (decreases in dopamine release and in dopamine D2 receptors in striatum) and this is associated with reduced activity of the orbitofrontal cortex (neuroanatomical region involved with salience attribution and motivation and implicated in compulsive behaviors) and the cingulate gyrus (neuroanatomical region involved with inhibitory control and attention and implicated in impulsivity). However, when addicted subjects are exposed to drug-related stimuli, these hypoactive regions become hyperactive in proportion to the expressed desire for the drug. We postulate that decreased dopamine function in addicted subjects results in decreased sensitivity to nondrug-related stimuli (including natural reinforcers) and disrupts frontal inhibition, both of which contribute to compulsive drug intake and impaired inhibitory control. These findings suggest new strategies for pharmacological and behavioral treatments, which focus on enhancing DA function and restoring brain circuits disrupted by chronic drug use to help motivate the addicted subject in activities that provide alternative sources of reinforcement, counteract conditioned responses, enhance their ability to control their drive to take drugs and interfere with their compulsive administration.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/sj.mp.4001507", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2707642", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2483596", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2722668", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2484107", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2483459", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2443069", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1115540", 
            "issn": [
              "1359-4184", 
              "1476-5578"
            ], 
            "name": "Molecular Psychiatry", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "9"
          }
        ], 
        "keywords": [
          "dopamine cells", 
          "dopamine function", 
          "involvement of dopamine", 
          "dopamine cell firing", 
          "chronic drug use", 
          "role of dopamine", 
          "drug-addicted subjects", 
          "effects of drugs", 
          "hypoactive regions", 
          "cingulate gyrus", 
          "DA function", 
          "drug reinforcement", 
          "supraphysiological activation", 
          "drug use", 
          "brain circuits", 
          "cell firing", 
          "drug-related stimuli", 
          "behavioral treatment", 
          "orbitofrontal cortex", 
          "drug abuse", 
          "treatment implications", 
          "DA increase", 
          "drugs", 
          "dopamine", 
          "drug addiction", 
          "frontal inhibition", 
          "reduced activity", 
          "compulsive drug", 
          "inhibitory control", 
          "subjects", 
          "salient stimuli", 
          "subject results", 
          "addiction", 
          "stimuli", 
          "abuse", 
          "cells", 
          "cortex", 
          "gyrus", 
          "study", 
          "administration", 
          "response", 
          "treatment", 
          "new strategy", 
          "activity", 
          "inhibition", 
          "environmental events", 
          "role", 
          "duration", 
          "involvement", 
          "activation", 
          "increase", 
          "events", 
          "firing", 
          "humans", 
          "function", 
          "proportion", 
          "findings", 
          "counteracts", 
          "fast increase", 
          "control", 
          "sensitivity", 
          "effect", 
          "results", 
          "alternative source", 
          "use", 
          "threshold", 
          "ability", 
          "addition", 
          "strategies", 
          "implications", 
          "intensity", 
          "region", 
          "desire", 
          "reinforcement", 
          "source", 
          "motivation", 
          "drive", 
          "circuit"
        ], 
        "name": "Dopamine in drug abuse and addiction: results from imaging studies and treatment implications", 
        "pagination": "557-569", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1003639866"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/sj.mp.4001507"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "15098002"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/sj.mp.4001507", 
          "https://app.dimensions.ai/details/publication/pub.1003639866"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-06-01T22:05", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_393.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/sj.mp.4001507"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.mp.4001507'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.mp.4001507'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.mp.4001507'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.mp.4001507'


     

    This table displays all metadata directly associated to this object as RDF triples.

    288 TRIPLES      22 PREDICATES      130 URIs      103 LITERALS      14 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/sj.mp.4001507 schema:about N1f8e27303abe4a2b8ae51fe96c122520
    2 N3c4a11b740b64891850fcb66b3a298aa
    3 N3f01633aec6a42ae8703a24203b85610
    4 N723988f6d8624f86928d8175e8d4fc74
    5 N7747e0a4006a4aadb0d7b55722717609
    6 Nd6f3ce311b914899ab6c82676c6f77d8
    7 Nf4fca7309af940e2a23a5a1610c56637
    8 anzsrc-for:11
    9 anzsrc-for:1109
    10 schema:author N602d83fff1344599ad20cdb4e6d0b4e3
    11 schema:citation sg:pub.10.1007/bf02245566
    12 sg:pub.10.1007/bf02246020
    13 sg:pub.10.1007/bf02246489
    14 sg:pub.10.1007/s002130050207
    15 sg:pub.10.1007/s002130050365
    16 sg:pub.10.1007/s002130050756
    17 sg:pub.10.1016/s0893-133x(00)00100-7
    18 sg:pub.10.1016/s0893-133x(00)00162-7
    19 sg:pub.10.1016/s0893-133x(98)00066-9
    20 sg:pub.10.1038/19525
    21 sg:pub.10.1038/386827a0
    22 sg:pub.10.1038/386830a0
    23 sg:pub.10.1038/41567
    24 sg:pub.10.1038/nm1001-1151
    25 sg:pub.10.1038/nn798
    26 sg:pub.10.1038/nrd897
    27 sg:pub.10.1038/sj.mp.4000421
    28 sg:pub.10.1038/sj.mp.4000514
    29 sg:pub.10.1038/sj.npp.1300088
    30 schema:datePublished 2004-04-06
    31 schema:datePublishedReg 2004-04-06
    32 schema:description The involvement of dopamine in drug reinforcement is well recognized but its role in drug addiction is much less clear. Imaging studies have shown that the reinforcing effects of drugs of abuse in humans are contingent upon large and fast increases in dopamine that mimic but exceed in the intensity and duration those induced by dopamine cell firing to environmental events. In addition, imaging studies have also documented a role of dopamine in motivation, which appears to be encoded both by fast as well as smooth DA increases. Since dopamine cells fire in response to salient stimuli, the supraphysiological activation by drugs is likely to be experienced as highly salient (driving attention, arousal conditioned learning and motivation) and may also reset the thresholds required for environmental events to activate dopamine cells. Indeed, imaging studies have shown that in drug-addicted subjects, dopamine function is markedly disrupted (decreases in dopamine release and in dopamine D2 receptors in striatum) and this is associated with reduced activity of the orbitofrontal cortex (neuroanatomical region involved with salience attribution and motivation and implicated in compulsive behaviors) and the cingulate gyrus (neuroanatomical region involved with inhibitory control and attention and implicated in impulsivity). However, when addicted subjects are exposed to drug-related stimuli, these hypoactive regions become hyperactive in proportion to the expressed desire for the drug. We postulate that decreased dopamine function in addicted subjects results in decreased sensitivity to nondrug-related stimuli (including natural reinforcers) and disrupts frontal inhibition, both of which contribute to compulsive drug intake and impaired inhibitory control. These findings suggest new strategies for pharmacological and behavioral treatments, which focus on enhancing DA function and restoring brain circuits disrupted by chronic drug use to help motivate the addicted subject in activities that provide alternative sources of reinforcement, counteract conditioned responses, enhance their ability to control their drive to take drugs and interfere with their compulsive administration.
    33 schema:genre article
    34 schema:inLanguage en
    35 schema:isAccessibleForFree true
    36 schema:isPartOf N072f4b4cd23b4e3cbeeeea46906eff08
    37 N4a6c5daf0be841698b66525cd1e308ed
    38 sg:journal.1115540
    39 schema:keywords DA function
    40 DA increase
    41 ability
    42 abuse
    43 activation
    44 activity
    45 addiction
    46 addition
    47 administration
    48 alternative source
    49 behavioral treatment
    50 brain circuits
    51 cell firing
    52 cells
    53 chronic drug use
    54 cingulate gyrus
    55 circuit
    56 compulsive drug
    57 control
    58 cortex
    59 counteracts
    60 desire
    61 dopamine
    62 dopamine cell firing
    63 dopamine cells
    64 dopamine function
    65 drive
    66 drug abuse
    67 drug addiction
    68 drug reinforcement
    69 drug use
    70 drug-addicted subjects
    71 drug-related stimuli
    72 drugs
    73 duration
    74 effect
    75 effects of drugs
    76 environmental events
    77 events
    78 fast increase
    79 findings
    80 firing
    81 frontal inhibition
    82 function
    83 gyrus
    84 humans
    85 hypoactive regions
    86 implications
    87 increase
    88 inhibition
    89 inhibitory control
    90 intensity
    91 involvement
    92 involvement of dopamine
    93 motivation
    94 new strategy
    95 orbitofrontal cortex
    96 proportion
    97 reduced activity
    98 region
    99 reinforcement
    100 response
    101 results
    102 role
    103 role of dopamine
    104 salient stimuli
    105 sensitivity
    106 source
    107 stimuli
    108 strategies
    109 study
    110 subject results
    111 subjects
    112 supraphysiological activation
    113 threshold
    114 treatment
    115 treatment implications
    116 use
    117 schema:name Dopamine in drug abuse and addiction: results from imaging studies and treatment implications
    118 schema:pagination 557-569
    119 schema:productId N033855b068b247878e122a196ae3e827
    120 N4712149d6520465589087585cd654d79
    121 Ncb91c12a0d4647e0af087846059e4490
    122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003639866
    123 https://doi.org/10.1038/sj.mp.4001507
    124 schema:sdDatePublished 2022-06-01T22:05
    125 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    126 schema:sdPublisher N719ba9e9f1874be0ad7484fcabded416
    127 schema:url https://doi.org/10.1038/sj.mp.4001507
    128 sgo:license sg:explorer/license/
    129 sgo:sdDataset articles
    130 rdf:type schema:ScholarlyArticle
    131 N033855b068b247878e122a196ae3e827 schema:name pubmed_id
    132 schema:value 15098002
    133 rdf:type schema:PropertyValue
    134 N072f4b4cd23b4e3cbeeeea46906eff08 schema:issueNumber 6
    135 rdf:type schema:PublicationIssue
    136 N1f8e27303abe4a2b8ae51fe96c122520 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Neurons
    138 rdf:type schema:DefinedTerm
    139 N25040c43f7fd4ccd8887e050abaf0261 rdf:first sg:person.015403046757.84
    140 rdf:rest Nb21ed0b60bbb4eebb64e63f88e5fa897
    141 N3c4a11b740b64891850fcb66b3a298aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Brain
    143 rdf:type schema:DefinedTerm
    144 N3f01633aec6a42ae8703a24203b85610 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Dopamine
    146 rdf:type schema:DefinedTerm
    147 N4712149d6520465589087585cd654d79 schema:name doi
    148 schema:value 10.1038/sj.mp.4001507
    149 rdf:type schema:PropertyValue
    150 N4a6c5daf0be841698b66525cd1e308ed schema:volumeNumber 9
    151 rdf:type schema:PublicationVolume
    152 N602d83fff1344599ad20cdb4e6d0b4e3 rdf:first sg:person.01144035310.18
    153 rdf:rest N62bd51f3b85641abbc61df2b5ca3bf6f
    154 N62bd51f3b85641abbc61df2b5ca3bf6f rdf:first sg:person.0735132433.35
    155 rdf:rest N25040c43f7fd4ccd8887e050abaf0261
    156 N719ba9e9f1874be0ad7484fcabded416 schema:name Springer Nature - SN SciGraph project
    157 rdf:type schema:Organization
    158 N723988f6d8624f86928d8175e8d4fc74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Child
    160 rdf:type schema:DefinedTerm
    161 N7747e0a4006a4aadb0d7b55722717609 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Attention Deficit Disorder with Hyperactivity
    163 rdf:type schema:DefinedTerm
    164 Nb21ed0b60bbb4eebb64e63f88e5fa897 rdf:first sg:person.013047163317.72
    165 rdf:rest rdf:nil
    166 Ncb91c12a0d4647e0af087846059e4490 schema:name dimensions_id
    167 schema:value pub.1003639866
    168 rdf:type schema:PropertyValue
    169 Nd6f3ce311b914899ab6c82676c6f77d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    170 schema:name Substance-Related Disorders
    171 rdf:type schema:DefinedTerm
    172 Nf4fca7309af940e2a23a5a1610c56637 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Humans
    174 rdf:type schema:DefinedTerm
    175 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    176 schema:name Medical and Health Sciences
    177 rdf:type schema:DefinedTerm
    178 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
    179 schema:name Neurosciences
    180 rdf:type schema:DefinedTerm
    181 sg:grant.2443069 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.mp.4001507
    182 rdf:type schema:MonetaryGrant
    183 sg:grant.2483459 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.mp.4001507
    184 rdf:type schema:MonetaryGrant
    185 sg:grant.2483596 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.mp.4001507
    186 rdf:type schema:MonetaryGrant
    187 sg:grant.2484107 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.mp.4001507
    188 rdf:type schema:MonetaryGrant
    189 sg:grant.2707642 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.mp.4001507
    190 rdf:type schema:MonetaryGrant
    191 sg:grant.2722668 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.mp.4001507
    192 rdf:type schema:MonetaryGrant
    193 sg:journal.1115540 schema:issn 1359-4184
    194 1476-5578
    195 schema:name Molecular Psychiatry
    196 schema:publisher Springer Nature
    197 rdf:type schema:Periodical
    198 sg:person.01144035310.18 schema:affiliation grid-institutes:grid.36425.36
    199 schema:familyName Volkow
    200 schema:givenName N D
    201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144035310.18
    202 rdf:type schema:Person
    203 sg:person.013047163317.72 schema:affiliation grid-institutes:grid.266093.8
    204 schema:familyName Swanson
    205 schema:givenName J M
    206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013047163317.72
    207 rdf:type schema:Person
    208 sg:person.015403046757.84 schema:affiliation grid-institutes:grid.202665.5
    209 schema:familyName Wang
    210 schema:givenName G-J
    211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015403046757.84
    212 rdf:type schema:Person
    213 sg:person.0735132433.35 schema:affiliation grid-institutes:grid.202665.5
    214 schema:familyName Fowler
    215 schema:givenName J S
    216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735132433.35
    217 rdf:type schema:Person
    218 sg:pub.10.1007/bf02245566 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025660547
    219 https://doi.org/10.1007/bf02245566
    220 rdf:type schema:CreativeWork
    221 sg:pub.10.1007/bf02246020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016990125
    222 https://doi.org/10.1007/bf02246020
    223 rdf:type schema:CreativeWork
    224 sg:pub.10.1007/bf02246489 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038618321
    225 https://doi.org/10.1007/bf02246489
    226 rdf:type schema:CreativeWork
    227 sg:pub.10.1007/s002130050207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006734694
    228 https://doi.org/10.1007/s002130050207
    229 rdf:type schema:CreativeWork
    230 sg:pub.10.1007/s002130050365 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040792669
    231 https://doi.org/10.1007/s002130050365
    232 rdf:type schema:CreativeWork
    233 sg:pub.10.1007/s002130050756 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003741794
    234 https://doi.org/10.1007/s002130050756
    235 rdf:type schema:CreativeWork
    236 sg:pub.10.1016/s0893-133x(00)00100-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018257913
    237 https://doi.org/10.1016/s0893-133x(00)00100-7
    238 rdf:type schema:CreativeWork
    239 sg:pub.10.1016/s0893-133x(00)00162-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046522838
    240 https://doi.org/10.1016/s0893-133x(00)00162-7
    241 rdf:type schema:CreativeWork
    242 sg:pub.10.1016/s0893-133x(98)00066-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053553631
    243 https://doi.org/10.1016/s0893-133x(98)00066-9
    244 rdf:type schema:CreativeWork
    245 sg:pub.10.1038/19525 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006488209
    246 https://doi.org/10.1038/19525
    247 rdf:type schema:CreativeWork
    248 sg:pub.10.1038/386827a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052945590
    249 https://doi.org/10.1038/386827a0
    250 rdf:type schema:CreativeWork
    251 sg:pub.10.1038/386830a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008799479
    252 https://doi.org/10.1038/386830a0
    253 rdf:type schema:CreativeWork
    254 sg:pub.10.1038/41567 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019786931
    255 https://doi.org/10.1038/41567
    256 rdf:type schema:CreativeWork
    257 sg:pub.10.1038/nm1001-1151 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046230934
    258 https://doi.org/10.1038/nm1001-1151
    259 rdf:type schema:CreativeWork
    260 sg:pub.10.1038/nn798 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046908280
    261 https://doi.org/10.1038/nn798
    262 rdf:type schema:CreativeWork
    263 sg:pub.10.1038/nrd897 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026706324
    264 https://doi.org/10.1038/nrd897
    265 rdf:type schema:CreativeWork
    266 sg:pub.10.1038/sj.mp.4000421 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013128731
    267 https://doi.org/10.1038/sj.mp.4000421
    268 rdf:type schema:CreativeWork
    269 sg:pub.10.1038/sj.mp.4000514 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031823330
    270 https://doi.org/10.1038/sj.mp.4000514
    271 rdf:type schema:CreativeWork
    272 sg:pub.10.1038/sj.npp.1300088 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052285316
    273 https://doi.org/10.1038/sj.npp.1300088
    274 rdf:type schema:CreativeWork
    275 grid-institutes:grid.202665.5 schema:alternateName Chemistry Department, Brookhaven National Laboratory, Upton, NY, USA
    276 Medical Department, Brookhaven National Laboratory, Upton, NY, USA
    277 schema:name Chemistry Department, Brookhaven National Laboratory, Upton, NY, USA
    278 Medical Department, Brookhaven National Laboratory, Upton, NY, USA
    279 rdf:type schema:Organization
    280 grid-institutes:grid.266093.8 schema:alternateName Department of Pediatrics, University of California, Irvine, CA, USA
    281 schema:name Department of Pediatrics, University of California, Irvine, CA, USA
    282 rdf:type schema:Organization
    283 grid-institutes:grid.36425.36 schema:alternateName Department of Psychiatry, State University of New York at Stony Brook, Stony Brook, NY, USA
    284 schema:name Department of Psychiatry, State University of New York at Stony Brook, Stony Brook, NY, USA
    285 Medical Department, Brookhaven National Laboratory, Upton, NY, USA
    286 National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA
    287 National Institute on Drug Abuse, Bethesda, MD, USA
    288 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...